title: Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection.
authors.affiliation: Pittsburgh Transplant Institute, University of Pittsburgh Health Science Center, Pennsylvania 15213.
authors.forename: L A
authors.initials: LA
authors.lastname: Valdivia
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: S
authors.initials: S
authors.lastname: Celli
authors.forename: F
authors.initials: F
authors.lastname: Pan
authors.forename: M
authors.initials: M
authors.lastname: Tsugita
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000818:Animals; D003165:Complement System Proteins / Q000276:immunology*; D006224:Cricetinae; D003520:Cyclophosphamide / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology*; D007106:Immune Sera / Q000008:administration & dosage / Q000276:immunology; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology*; D051381:Rats; D011917:Rats, Inbred Lew; D013045:Species Specificity; D016559:Tacrolimus / Q000627:therapeutic use; D014183:Transplantation, Heterologous / Q000276:immunology*
chemical_list: D007106:Immune Sera; D003520:Cyclophosphamide; D003165:Complement System Proteins; D016559:Tacrolimus